title: Leukocytoclastic vasculitis: is propranolol implicated?
abstract: Drugs frequently cause cutaneous adverse reactions. The suspected agent is sometimes difficult to identify, especially in patients receiving multidrug treatment and with underlying illnesses that may contribute to the clinical picture. In our patient, propranolol-induced leukocytoclastic vasculitis was diagnosed by exclusion.
authors.affiliation: Department of Clinical Therapeutics, Athens University, Greece.
authors.forename: A
authors.initials: A
authors.lastname: Iliopoulou
authors.forename: G
authors.initials: G
authors.lastname: Giannakopoulos
authors.forename: A
authors.initials: A
authors.lastname: Synetos
authors.forename: A
authors.initials: A
authors.lastname: Georgiou
authors.forename: A
authors.initials: A
authors.lastname: Chalkiadaki
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000368:Aged; D004578:Electron Spin Resonance Spectroscopy; D006801:Humans; D008297:Male; D011433:Propranolol / Q000009:adverse effects*; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000139:chemically induced*
chemical_list: D000319:Adrenergic beta-Antagonists; D011433:Propranolol